DV1 TFA is a selective antagonist of the CXC chemokine receptor 4 (CXCR4). It exhibits antiviral activity by blocking the entry of HIV-1 via the CXCR4 coreceptor.
Target:
HIV Protease|||CXCR
* VAT and and shipping costs not included. Errors and price changes excepted
